标普和纳斯达克内在价值 联系我们

Allied Corp. ALID OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Allied Corp. (ALID) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 16/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
17/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
护城河
15/100
→ Income
~
成长
58/100
→ Income
收入
10/100
→ Income

估值概览 — ALID

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.67
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.11
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $0.00 $0.00 $0.00 -
2015 $0.00 $9K $-7.53K -83.7%
2016 $0.00 $0.00 $-2.06K -
2017 $0.00 $0.00 $-20.25K -
2018 $0.00 $0.00 $-19.25K -
2019 $0.00 $0.00 $-23.11K -
2020 $-0.08 $0.00 $-6.76M -
2021 $-0.15 $12.52K $-12.16M -97133.6%
2022 $-0.18 $165.6K $-16.77M -10129%
2023 $-0.11 $72.1K $-10.68M -14807.6%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言